The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kreisel, D.
Right arrow Articles by Rosengard, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kreisel, D.
Right arrow Articles by Rosengard, B. R.
The Journal of Immunology, 2004, 173: 3027-3034.
Copyright © 2004 by The American Association of Immunologists

Vascular Endothelium Does Not Activate CD4+ Direct Allorecognition in Graft Rejection1

Daniel Kreisel2,*, Alyssa M. Krasinskas2,{dagger}, Alexander S. Krupnick*, Andrew E. Gelman*, Keki R. Balsara*, Sicco H. Popma*, Markus Riha*, Ariella M. Rosengard{dagger}, Laurence A. Turka{ddagger} and Bruce R. Rosengard3,*

Departments of * Surgery, {dagger} Pathology and Laboratory Medicine, and {ddagger} Medicine, University of Pennsylvania Health System, Philadelphia, PA 19104

Expression of MHC class II by donor-derived APCs has been shown to be important for allograft rejection. It remains controversial, however, whether nonhemopoietic cells, such as vascular endothelium, possess Ag-presenting capacity to activate alloreactive CD4+ T lymphocytes. This issue is important in transplantation, because, unlike hemopoietic APCs, allogeneic vascular endothelium remains present for the life of the organ. In this study we report that cytokine-activated vascular endothelial cells are poor APCs for allogeneic CD4+ T lymphocytes in vitro and in vivo despite surface expression of MHC class II. Our in vitro observations were extended to an in vivo model of allograft rejection. We have separated the allostimulatory capacity of endothelium from that of hemopoietic APCs by using bone marrow chimeras. Hearts that express MHC class II on hemopoietic APCs are acutely rejected in a mean of 7 days regardless of the expression of MHC class II on graft endothelium. Alternatively, hearts that lack MHC class II on hemopoietic APCs are acutely rejected at a significantly delayed tempo regardless of the expression of MHC class II on graft endothelium. Our data suggest that vascular endothelium does not play an important role in CD4+ direct allorecognition and thus does not contribute to the vigor of acute rejection.




This article has been cited by other articles:


Home page
Int ImmunolHome page
A. Ito, H. Shimura, A. Nitahara, K. Tomiyama, M. Ito, T. Kanekura, K. Okumura, H. Yagita, and K. Kawai
NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway
Int. Immunol., October 1, 2008; 20(10): 1343 - 1349.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. D. Manes and J. S. Pober
Antigen Presentation by Human Microvascular Endothelial Cells Triggers ICAM-1-Dependent Transendothelial Protrusion by, and Fractalkine-Dependent Transendothelial Migration of, Effector Memory CD4+ T Cells
J. Immunol., June 15, 2008; 180(12): 8386 - 8392.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Bolinger, P. Krebs, Y. Tian, D. Engeler, E. Scandella, S. Miller, D. C. Palmer, N. P. Restifo, P.-A. Clavien, and B. Ludewig
Immunologic ignorance of vascular endothelial cells expressing minor histocompatibility antigen
Blood, May 1, 2008; 111(9): 4588 - 4595.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. E. Gelman, M. Okazaki, J. Lai, C. G. Kornfeld, F. H. Kreisel, S. B. Richardson, S. Sugimoto, J. R. Tietjens, G. A. Patterson, A. S. Krupnick, et al.
CD4+ T Lymphocytes Are Not Necessary for the Acute Rejection of Vascularized Mouse Lung Transplants
J. Immunol., April 1, 2008; 180(7): 4754 - 4762.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. A. Rao, K. J. Tracey, and J. S. Pober
IL-1{alpha} and IL-1beta Are Endogenous Mediators Linking Cell Injury to the Adaptive Alloimmune Response
J. Immunol., November 15, 2007; 179(10): 6536 - 6546.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. C. Cuffy, A. M. Silverio, L. Qin, Y. Wang, R. Eid, G. Brandacher, F. G. Lakkis, D. Fuchs, J. S. Pober, and G. Tellides
Induction of Indoleamine 2,3-Dioxygenase in Vascular Smooth Muscle Cells by Interferon-{gamma} Contributes to Medial Immunoprivilege
J. Immunol., October 15, 2007; 179(8): 5246 - 5254.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. Tellides and J. S. Pober
Interferon-{gamma} Axis in Graft Arteriosclerosis
Circ. Res., March 16, 2007; 100(5): 622 - 632.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. D. Manes, S. L. Shiao, T. J. Dengler, and J. S. Pober
TCR Signaling Antagonizes Rapid IP-10-Mediated Transendothelial Migration of Effector Memory CD4+ T Cells
J. Immunol., March 1, 2007; 178(5): 3237 - 3243.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Landais, A. Morice, H. M. Long, T. A. Haigh, B. Charreau, M. Bonneville, G. S. Taylor, and E. Houssaint
EBV-Specific CD4+ T Cell Clones Exhibit Vigorous Allogeneic Responses
J. Immunol., August 1, 2006; 177(3): 1427 - 1433.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Religa, R. Cao, M. Bjorndahl, Z. Zhou, Z. Zhu, and Y. Cao
Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels
Blood, December 15, 2005; 106(13): 4184 - 4190.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. S. Krupnick, A. E. Gelman, W. Barchet, S. Richardson, F. H. Kreisel, L. A. Turka, M. Colonna, G. A. Patterson, and D. Kreisel
Cutting Edge: Murine Vascular Endothelium Activates and Induces the Generation of Allogeneic CD4+25+Foxp3+ Regulatory T Cells
J. Immunol., November 15, 2005; 175(10): 6265 - 6270.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Bagai, A. Valujskikh, D. H. Canaday, E. Bailey, P. N. Lalli, C. V. Harding, and P. S. Heeger
Mouse Endothelial Cells Cross-Present Lymphocyte-Derived Antigen on Class I MHC via a TAP1- and Proteasome-Dependent Pathway
J. Immunol., June 15, 2005; 174(12): 7711 - 7715.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. Mestas, S. P. Crampton, T. Hori, and C. C. W. Hughes
Endothelial cell co-stimulation through OX40 augments and prolongs T cell cytokine synthesis by stabilization of cytokine mRNA
Int. Immunol., June 1, 2005; 17(6): 737 - 747.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.